TrkB, sometimes in conjunction with its ligand, BDNF, is often overexpressed in different human cancers including neuroblastomas, Wilms's tumor, and prostate and pancreatic adenocarcinomas, as well as multiple myeloma, a nonsolid tumor [9]. Here, NTRK2 is linked to neoplasm.